[ ]for the benefit of the population let’s call for United Nations to develop a similar regulatory environment for vaccines, in a timely manner to protect them from serious diseases which know no borders 2 The challenge The pharmaceutical industry is highly regulated The number of quality control tests on each vaccine batch varies between 100 and more than 1000, and testing accounts for up to 70% of production time [ ]each batch of vaccine released by the manufacturer is retested and released by a National Control Laboratory (NCL) of a reference country as well as by some NCLs upon importation, resulting in multiple tests on the same batch [ ]stocks of vaccine at different production stages using “pre-change” processes must be constituted to cover demand during the period until all regulators have approved the change, which is both challenging and costly [ ]the aircraft manufacturer and owner are periodically audited by authorities alongside regular regional assessments
What can vaccines learn from aviation?